2024 Global Beta-2 Microglobulin Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities

August 2024 | | ID: 21179F342050EN
Venture Planning Group

Abstracts

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.This report presents a detailed analysis of the Я-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.Contains 243 pages and 9 tables

Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Clinical Significance
and Laboratory Practices
B. Instrumentation Review And
Market Needs

1. ABBOTT AXSYM

2. ABBOTT ARCHITECT C4000

3. ABBOTT ARCHITECT I2000 SERIES

4. ABBOTT ARCHITECT CI8200 SYSTEM

5. BECKMAN COULTER UNICEL SERIES

6. BECKMAN COULTER ACCESS

7. BINDING SITE ESP600

8. BIOMERIEUX MINI VIDAS

9. CAROLINA CHEMISTRIES BIOLIS 24I

10. DIASORIN LIAISON

11. HORIBA ABX PENTRA

12. INVERNESS DS2

13. J&J VITROS ECI/ECIQ

14. J&J VITROS 3600

15. J&J VITROS 5600

16. OLYMPUS AU5400

17. OLYMPUS AU3000I

18. OLYMPUS AU2700

19. ROCHE MODULAR ANALYTICS

20. ROCHE COBAS INTEGRA

21. ROCHE COBAS INTEGRA 400 PLUS

22. ROCHE ELECSYS

23. ROCHE COBAS C311

24. SIEMENS ADVIA CENTAUR

25. SIEMENS DIMENSION

26. SIEMENS DIMENSION RXL MAX

27. SIEMENS DIMENSION VISTA

28. SIEMENS IMMULITE



29. SIEMENS STRATUS

30. TOSOH AIA-SERIES

31. VITAL DIAGNOSTICS ATAC 8000

32. VITAL DIAGNOSTICS ENVOY

C. Current and Emerging Technologies

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay

3. MOLECULAR DIAGNOSTICS

a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others

4. CHROMOSOME ANALYSIS

a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)